Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lysophospholipids | 3 | 2018 | 26 | 1.270 |
Why?
|
| Ovarian Neoplasms | 2 | 2018 | 84 | 0.810 |
Why?
|
| Cysteine | 4 | 2017 | 145 | 0.630 |
Why?
|
| Cell Proliferation | 5 | 2018 | 603 | 0.620 |
Why?
|
| Antioxidants | 2 | 2018 | 122 | 0.580 |
Why?
|
| Reactive Oxygen Species | 3 | 2018 | 163 | 0.500 |
Why?
|
| Signal Transduction | 5 | 2014 | 727 | 0.460 |
Why?
|
| Hydrogen Peroxide | 1 | 2014 | 85 | 0.400 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 478 | 0.390 |
Why?
|
| Cell Line, Tumor | 4 | 2018 | 729 | 0.300 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2004 | 41 | 0.300 |
Why?
|
| Sulfenic Acids | 3 | 2014 | 57 | 0.240 |
Why?
|
| Oxidation-Reduction | 3 | 2017 | 274 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2014 | 74 | 0.230 |
Why?
|
| Phospholipase D | 1 | 2004 | 6 | 0.210 |
Why?
|
| Interleukin-8 | 1 | 2004 | 22 | 0.210 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 32 | 0.210 |
Why?
|
| Isoenzymes | 1 | 2004 | 67 | 0.210 |
Why?
|
| Apoptosis | 3 | 2018 | 375 | 0.200 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 2002 | 4 | 0.190 |
Why?
|
| Receptors, Eicosanoid | 1 | 2002 | 5 | 0.190 |
Why?
|
| Receptors, Lysophosphatidic Acid | 2 | 2014 | 6 | 0.190 |
Why?
|
| MAP Kinase Signaling System | 1 | 2002 | 65 | 0.190 |
Why?
|
| Proteins | 3 | 2010 | 149 | 0.190 |
Why?
|
| Protein-Serine-Threonine Kinases | 1 | 2002 | 49 | 0.190 |
Why?
|
| Phosphorylation | 3 | 2010 | 250 | 0.170 |
Why?
|
| Prostatic Neoplasms | 2 | 2004 | 489 | 0.170 |
Why?
|
| Enzyme Activation | 3 | 2010 | 138 | 0.140 |
Why?
|
| Cell Death | 1 | 2018 | 79 | 0.130 |
Why?
|
| Paclitaxel | 1 | 2018 | 57 | 0.130 |
Why?
|
| Cisplatin | 1 | 2018 | 78 | 0.130 |
Why?
|
| Protein Transport | 2 | 2014 | 80 | 0.120 |
Why?
|
| Humans | 11 | 2018 | 32284 | 0.120 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2006 | 68 | 0.110 |
Why?
|
| Phenylpropionates | 1 | 2014 | 3 | 0.110 |
Why?
|
| Endosomes | 1 | 2014 | 13 | 0.100 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2014 | 19 | 0.100 |
Why?
|
| Vesicular Transport Proteins | 1 | 2014 | 12 | 0.100 |
Why?
|
| Benzamides | 1 | 2014 | 60 | 0.100 |
Why?
|
| Female | 4 | 2018 | 19947 | 0.100 |
Why?
|
| Cyclohexanones | 2 | 2010 | 20 | 0.090 |
Why?
|
| Onium Compounds | 1 | 2010 | 2 | 0.080 |
Why?
|
| Genes, Reporter | 1 | 2010 | 41 | 0.080 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 33 | 0.080 |
Why?
|
| Pyridines | 1 | 2010 | 79 | 0.080 |
Why?
|
| NF-kappa B | 1 | 2010 | 84 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2010 | 193 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2010 | 132 | 0.080 |
Why?
|
| Staining and Labeling | 1 | 2010 | 63 | 0.080 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2008 | 6 | 0.070 |
Why?
|
| Luminescent Proteins | 1 | 2008 | 25 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2008 | 52 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2007 | 58 | 0.070 |
Why?
|
| Lymphocyte Activation | 1 | 2007 | 94 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2007 | 37 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2007 | 43 | 0.060 |
Why?
|
| Cell Line | 2 | 2008 | 454 | 0.060 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2004 | 33 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2004 | 160 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2007 | 99 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2004 | 164 | 0.060 |
Why?
|
| Albumins | 1 | 2004 | 42 | 0.050 |
Why?
|
| Lipoproteins, LDL | 1 | 2004 | 99 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2005 | 251 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2004 | 17 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2004 | 104 | 0.050 |
Why?
|
| Cyclooxygenase 2 | 1 | 2004 | 51 | 0.050 |
Why?
|
| Transfection | 1 | 2004 | 204 | 0.050 |
Why?
|
| Male | 3 | 2014 | 19443 | 0.050 |
Why?
|
| Benzoquinones | 1 | 2002 | 5 | 0.050 |
Why?
|
| Stimulation, Chemical | 1 | 2002 | 16 | 0.050 |
Why?
|
| Pertussis Toxin | 1 | 2002 | 19 | 0.050 |
Why?
|
| Platelet Activating Factor | 1 | 2002 | 15 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2002 | 40 | 0.050 |
Why?
|
| Indoles | 1 | 2002 | 65 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2004 | 243 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 83 | 0.050 |
Why?
|
| Neutrophils | 1 | 2002 | 120 | 0.040 |
Why?
|
| Neoplasms | 1 | 2006 | 754 | 0.040 |
Why?
|
| Mass Spectrometry | 2 | 2010 | 98 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2010 | 78 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2004 | 762 | 0.040 |
Why?
|
| Animals | 5 | 2010 | 8199 | 0.030 |
Why?
|
| Nucleotides | 1 | 2017 | 17 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2017 | 25 | 0.030 |
Why?
|
| Circular Dichroism | 1 | 2017 | 39 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2017 | 68 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2017 | 75 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2017 | 204 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2017 | 111 | 0.030 |
Why?
|
| Biotinylation | 1 | 2010 | 12 | 0.020 |
Why?
|
| Organelles | 1 | 2008 | 4 | 0.020 |
Why?
|
| Golgi Apparatus | 1 | 2008 | 10 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2008 | 74 | 0.020 |
Why?
|
| Rhodamines | 1 | 2007 | 6 | 0.020 |
Why?
|
| Biotin | 1 | 2007 | 7 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2007 | 8 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2007 | 9 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2007 | 19 | 0.020 |
Why?
|
| Cyclohexenes | 1 | 2007 | 17 | 0.020 |
Why?
|
| Sulfinic Acids | 1 | 2007 | 14 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2007 | 32 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2007 | 58 | 0.020 |
Why?
|
| Antigens | 1 | 2007 | 34 | 0.020 |
Why?
|
| Actins | 1 | 2007 | 54 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2007 | 33 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2007 | 59 | 0.020 |
Why?
|
| Kinetics | 1 | 2007 | 250 | 0.020 |
Why?
|
| Lipids | 1 | 2008 | 253 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 215 | 0.020 |
Why?
|
| Calcium | 1 | 2008 | 339 | 0.010 |
Why?
|
| Models, Animal | 1 | 2006 | 188 | 0.010 |
Why?
|
| Protein Carbonylation | 1 | 2005 | 3 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 2005 | 7 | 0.010 |
Why?
|
| Risk | 1 | 2006 | 305 | 0.010 |
Why?
|
| Copper | 1 | 2005 | 11 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2005 | 24 | 0.010 |
Why?
|
| Phosphatidylethanolamines | 1 | 2004 | 8 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2006 | 188 | 0.010 |
Why?
|
| Linoleic Acid | 1 | 2004 | 19 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 2004 | 29 | 0.010 |
Why?
|
| Fish Oils | 1 | 2004 | 38 | 0.010 |
Why?
|
| Triglycerides | 1 | 2004 | 235 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2005 | 255 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 315 | 0.010 |
Why?
|
| Cholesterol | 1 | 2004 | 262 | 0.010 |
Why?
|
| Models, Biological | 1 | 2005 | 408 | 0.010 |
Why?
|
| Acetyltransferases | 1 | 2002 | 3 | 0.010 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2002 | 7 | 0.010 |
Why?
|
| Calcimycin | 1 | 2002 | 8 | 0.010 |
Why?
|
| Acyltransferases | 1 | 2002 | 18 | 0.010 |
Why?
|
| Phospholipases A | 1 | 2002 | 31 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 174 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 2571 | 0.010 |
Why?
|